You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 49348-0636


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49348-0636

Drug NameNDCPrice/Unit ($)UnitDate
SM LORATADINE 5 MG/5 ML SYRUP 49348-0636-34 0.04118 ML 2025-04-23
SM LORATADINE 5 MG/5 ML SYRUP 49348-0636-34 0.04133 ML 2025-03-19
SM LORATADINE 5 MG/5 ML SYRUP 49348-0636-34 0.04165 ML 2025-02-19
SM LORATADINE 5 MG/5 ML SYRUP 49348-0636-34 0.03906 ML 2025-01-22
SM LORATADINE 5 MG/5 ML SYRUP 49348-0636-34 0.03842 ML 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 49348-0636

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC 49348-0636

Understanding NDC Codes

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what an NDC is. An NDC is a unique 11-digit, 3-segment code assigned to each medication under Section 510 of the US Federal Food, Drug, and Cosmetic Act. This code helps in identifying the drug, its manufacturer, and its packaging[2].

Identifying the Drug

The NDC 49348-0636 corresponds to a specific drug product. However, the provided sources do not directly mention this NDC. To proceed, we need to identify the drug associated with this NDC, which typically involves checking databases such as the FDA's database or the Medicaid Drug Rebate Program listings.

Market Context

General Market Trends

The overall prescription drug market is expected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by increasing demand for healthcare services, advancements in pharmaceutical technology, and an aging population[4].

Regulatory Environment

Drugs must meet specific regulatory requirements to be considered covered outpatient drugs. For instance, the FDA determines whether a drug has an approved New Drug Application (NDA), which is crucial for inclusion in the Medicaid Drug Rebate Program. Drugs without approved NDAs are subject to enforcement action and cannot be marketed without appropriate FDA approval[1][5].

Pricing Mechanisms

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

For drugs participating in the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price[2].

Example Pricing Calculation

While the specific details for NDC 49348-0636 are not provided, here is a general example of how the pricing might be calculated:

  • AMP: The average price at which the manufacturer sells the drug to wholesalers.
  • URA: The rebate amount that the manufacturer must pay for each unit sold.
  • Ceiling Price: AMP - URA, then multiplied by the package size and case pack size.

Price Projections

Historical Pricing Data

To project future prices, historical pricing data is essential. For example, if we look at another drug like Linezolid (NDC 00054-0319), the price per unit has fluctuated over time but generally follows market trends. In 2024, the price per unit ranged from $1.69 to $1.95 per mL[4].

Market Growth and Inflation

Given the expected growth in the prescription drug market, it is reasonable to assume that prices will increase, albeit at a rate that may be influenced by regulatory controls and market competition.

Industry Predictions and Trends

Role of AI and Data Analytics

In 2025, the pharmaceutical industry is expected to increasingly adopt artificial intelligence (AI) and external data to enhance decision-making and operational efficiency. This could lead to more precise pricing strategies and better market forecasting[3].

Regulatory Compliance

Ensuring that the drug is compliant with FDA regulations is critical. Any changes in regulatory status can significantly impact pricing and market inclusion.

Key Takeaways

  • NDC Identification: Understanding the specific drug associated with NDC 49348-0636 is crucial for accurate analysis.
  • Market Trends: The prescription drug market is expected to grow at a CAGR of 9% through 2030.
  • Regulatory Compliance: Ensuring FDA approval and compliance with Medicaid Drug Rebate Program requirements is essential.
  • Pricing Mechanisms: Prices are calculated based on AMP, URA, package size, and case pack size.
  • AI and Data Analytics: Increased use of AI and external data will influence pricing strategies and market forecasting.

FAQs

  1. What is an NDC code?

    • An NDC code is a unique 11-digit code assigned to each medication under Section 510 of the US Federal Food, Drug, and Cosmetic Act.
  2. How are prices calculated for drugs in the Medicaid Drug Rebate Program?

    • Prices are calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) and then adjusting for package size and case pack size.
  3. What impact does FDA approval have on drug pricing?

    • FDA approval is crucial for a drug to be considered a covered outpatient drug. Without approval, the drug cannot be marketed and is not eligible for inclusion in the rebate program.
  4. How does the adoption of AI influence drug pricing?

    • AI can enhance decision-making and operational efficiency, leading to more precise pricing strategies and better market forecasting.
  5. What are the general trends in the prescription drug market?

    • The prescription drug market is expected to grow at a CAGR of 9% through 2030, driven by increasing demand and technological advancements.

Sources

  1. For State Medicaid Directors - Medicaid.gov
  2. NDC Product Details - HRSA
  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch - Intelligencia.ai
  4. Latest drug prices and trends for NDC 00054-0319 - DrugPatentWatch
  5. For State Medicaid Directors - Medicaid.gov

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.